Evaluation of the Effectiveness of iPACK and Adductor Canal Blocks on Patients Undergoing Arthroscopic Knee Surgery

NCT07002580 | Recruiting

• 1 other identifier: E-43012747-050.04-463720-202
• Study Type: interventional
• Target: 64
• Locations: 1 country
• Sites: 1

Brief Summary

Arthroscopic knee surgery is one of the most commonly performed procedures in orthopedic surgery. More than 50% of patients experience moderate to severe pain after the operation. Inadequate postoperative pain control and poor recovery quality can negatively impact physiotherapy protocols, prolong hospital stays, and consequently lead to cognitive dysfunction, systemic infections, and increased healthcare costs. Therefore, reducing postoperative pain and improving recovery quality are of great importance. In our clinic, a variety of analgesic techniques are routinely employed as part of a multimodal analgesia approach for patients undergoing arthroscopic knee surgery. One of these techniques is the simultaneous application of the IPACK block and the adductor canal block. In this study, we aim to evaluate the effectiveness of these blocks on postoperative recovery quality in patients undergoing arthroscopic knee surgery.

Conditions

Patients Undergoing Arthroscopic Knee Surgery

Keywords

Arthroscopic Knee Surgery; Perifheric Nerve Block; Analgesia; iPACK; Adductor Canal Block; QoR-15

Outcome Measures

Primary Outcomes (1)

• Quality of Recovery

  Quality of Recovery of the patients will be assessed with QoR-15 questionnaire. Its scoring will range between 0 and 150 points.

  24 hours.

Secondary Outcomes (1)

• Analgesic Consumption

  24 hours.

Study Arms (2)

Group 1

EXPERIMENTAL

Group 1 will involve the patients which will be applied iPACK and adductor canal blocks in addition to spinal anesthesia.

Procedure: IPACK and adductor canal block with Bupivacaine 0.25%; Procedure: Spinal Anesthesia with Bupivacaine

Group 2

EXPERIMENTAL

Group 2 will involve the patients which will be applied only spinal anesthesia without additional peripheric nerve blocks.

Procedure: Spinal Anesthesia with Bupivacaine

Interventions

IPACK and adductor canal block with Bupivacaine 0.25% PROCEDURE

iPACK block is infiltration between the Popliteal Artery and the Capsule of the Knee. iPACK and adductor canal blocks are performed with ultrasound guidence under sterile conditions.

Group 1

Spinal Anesthesia with Bupivacaine PROCEDURE

Spinal Anesthesia is a basic anesthesia method used for years to grant anesthesia for surgeries for lower extremities and lower torso surgeries.

Group 1; Group 2

Eligibility Criteria

• Age: 18 Years - 50 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Patients aged between 18 and 50 years,
• Scheduled for arthroscopic knee surgery under spinal anesthesia due to knee pathology
• Patients classified as ASA physical status I-II-III according to the American Society of Anesthesiologists risk classification

You may not qualify if:

• Coagulopathy
• ASA IV-V patients
• Uncooperable patients
• Patients who refuses to participate in study
• Patients who takes chronic pain treatments

Sponsors & Collaborators

• Sakarya University: lead

Study Sites (1)

Sakarya University Training and Research Hospital

Sakarya, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Agnosia

Interventions

Anesthesia, Spinal; Bupivacaine

Condition Hierarchy (Ancestors)

Perceptual Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anesthesia, Conduction; Anesthesia; Anesthesia and Analgesia; Anilides; Amides; Organic Chemicals; Aniline Compounds; Amines

Central Study Contacts

Oğuzhan Okumuş, M.D.

CONTACT

+905372093019; dr.oguzhanokumusss@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Masking Details: Patients will be randomized with closed letter method.
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Resident M.D.

Study Record Dates

• First Submitted: May 15, 2025
• First Posted: June 3, 2025
• Study Start: July 1, 2025
• Primary Completion: January 1, 2026
• Study Completion: April 1, 2026
• Last Updated: February 6, 2026

Record last verified: 2025-05

Locations

TU (1)